Skip to main content

Table 2 Correlations of functional and morphological properties of the arterial wall with clinical and laboratory parameters before PCSK9i treatment

From: Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors

Parameter

FMD

PWV

c-IMT

Age (years)

r = -0.305; p = 0.002

r = -0.247; p = 0.013

r = -0.488; p < 0.0001

Body mass index (kg/m2)

r = -0.059; p = 0.56

r = 0.104; p = 0.302

r = 0.161; p = 0.112

Systolic blood pressure (mm Hg)

r = -0.094; p = 0.35

r = -0.299; p = 0.003

r = 0.207; p = 0.040

Diastolic blood pressure (mm Hg)

r = -0.047; p = 0.64

r = 0.194; p = 0.053

r = 0.008; p = 0.937

Total cholesterol (mmol/l)

r = -0.021; p = 0.837

r = 0.076; p = 0.454

r = -0.029; p = 0.776

HDL cholesterol (mmol/l)

r = 0.014; p = 0.892

r = -0.009; p = 0.927

r = 0.106; p = 0.296

LDL cholesterol (mmol/l)

r = 0.046; p = 0.652

r = 0.081; p = 0.421

r = -0.102; p = 0.314

Triglycerides (mmol/l)

r = -0.153; p = 0.129

r = 0.018; p = 0.860

r = 0.066; p = 0.517

Lipoprotein (a) (mg/l)

r = -0.231; p = 0.020

r = 0.208; p = 0.038

r = -0.067; p = 0.510

Apolipoprotein B (g/l)

r = 0.003; p = 0.977

r = 0.062; p = 0.543

r = -0.043; p = 0.677

Apolipoprotein A1 (g/l)

r = 0.030; p = 0.772

r = -0.066; p = 0.517

r = 0.150; p = 0.144

hs-CRP (mg/l)

r = -0.263; p = 0.009

r = 0.079; p = 0.439

r = -0.094; p = 0.358

TNF-alpha (ng/l)

r = 0.050; p = 0.625

r = 0.171; p = 0.091

r = -0.020; p = 0.843

Il-6 (ng/l)

r = -0.012; p = 0.907

r = -0.055; p = 0.591

r = -0.016; p = 0.876

IL-8 (ng/l)

r = 0.048; p = 0.636

r = -0.035; p = 0.735

r = -0.053; p = 0.605

IL-10 (ng/l)

r = 0.071; p = 0.486

r = -0.078; p = 0.440

r = 0-.025; p = 0.808

VCAM1 (mg/l)

r = -0.225; p = 0.025

r = 0.042; p = 0.677

r = 0.037; p = 0.715

TAFI (%)

r = -0.060; p = 0.561

r = 0.109; p = 0.290

r = 0.215; p = 0.036

PAI-1 (ng/ml)

r = 0.030; p = 0.129

r = 0.218; p = 0.048

r = 0.256; p = 0.020

OCP (Abs-sum)

r = -0.234 p = 0.021

r = 0.057 p = 0.577

r = 0.264 p = 0.009

OFP (%)

r = 0.119; p = 0.2 44

r = -0.054; p = 0.602

r = 0.004; p = 0.971

OHP (Abs-sum)

r = -0.264; p = 0.009

r = 0.093; p = 0.367

r = 0.144; p = 0.161

  1. FMD flow mediated dilation, PWV pulse wave velocity, c-IMT carotid intima media thickness, HDL cholesterol high density lipoprotein cholesterol, LDL cholesterol low density lipoprotein cholesterol, hs-CRP high-sensitivity C—reactive protein, TNF-alpha tumor necrosis factor alpha, IL-6 interleukin 6, IL-8 interleukin 8, IL-10 interleukin 10, VCAM1 vascular cell adhesion protein 1, TAFI thrombin activatable fibrinolysis inhibitor, PAI-1 plasminogen activator inhibitor 1, OCP overall coagulation potential, OFP overall fibrinolytic potential, OHP overall hemostasis potential